Propagenix For Profit

AxoGen is a biotech company developing treatment options for the reconstruction and repair of peripheral nerve injuries.

Last Funding Type: Venture - Series Unknown
Headquarters: United States
Investors Number: 4
Technology: Other
Industry: Regenerative medicine
Estimated Revenue: $100M to $500M
Total Funding: $95M